Related Experiment Videos
Synthesis and antiulcerogenic evaluation of 2-(substituted phenylimino)-2H-quinolizines
Journal of Pharmaceutical Sciences
|August 1, 1978
Abstract:
The synthesis and antiulcerogenic evaluation of a series of 2-(substituted phenylimino)-2H-quinolizines are described. The most active compound, the 4-chlorophenylimido derivative, inhibited ulcer formation by 98%.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment.
Digestive diseases and sciences·2001
Minimization and management of wastes from biomedical research.
Environmental health perspectives·2000
Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
Clinical therapeutics·2000
An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
Clinical therapeutics·1999
Machine learning-based stability optimization design and virtual screening of the anti-pulmonary fibrosis peptide DR3penA.
Journal of pharmaceutical sciences·2026
Comparison of bupivacaine concentrations in local tissue from three extended-release formulations in a pig incision model.
Journal of pharmaceutical sciences·2026
A machine learning-based model for predicting the color of liquid formulation placebos and analyzing their visual similarity.
Journal of pharmaceutical sciences·2026
In silico and in vitro immunogenicity risk assessment of process- and product-related protein impurities reported in adenoviral-vectored COVID-19 vaccines.
Journal of pharmaceutical sciences·2026
High-throughput in vitro lipolysis-permeation screening compared to in vivo drug exposure for a wide range of oral lipid-based formulations.
Journal of pharmaceutical sciences·2026
Evaluation of novel water soluble compositions of propofol for intravenous anesthesia.
Journal of pharmaceutical sciences·2026
In Silico Investigation of Candidate Anticancer Targets for Aryltetralin Lignans Previously Reported from Cleistanthus Species.
Molecules (Basel, Switzerland)·2026
QSAR Modeling and Fragment Contribution Analysis of N-Benzyltryptamines at Human 5-HT2 Receptor Subtypes.
Molecules (Basel, Switzerland)·2026
Identification of an Inhibitory Fraction from Cinnamomum cassia Against Digestive Lipases.
Molecules (Basel, Switzerland)·2026